Home/Evolus/Rui Avelar

RA

Rui Avelar

Chief Medical Officer

Therapeutic Areas

Medical Aesthetics

Evolus Pipeline

Drug	Indication	Phase
Jeuveau (prabotulinumtoxinA-xvfs)	Moderate to Severe Glabellar Lines	Approved
Evolysse Smooth	Wrinkles in Dynamic Facial Areas (e.g., NLFs)	Approved
Evolysse Form	Wrinkles in Dynamic Facial Areas (e.g., NLFs)	Approved

Leadership Team at Evolus

David Moatazedi

President and Chief Executive Officer

Lauren Silvernail

Chief Financial Officer

Michael J. Brown

General Counsel

Senior Vice President, Global Marketing and Commercial

View full Evolus profile